 首页

 情报

 原创

 专题

 报告

 链接

 直播

 活动

动脉网APP
扫码下载

晖致同意收购Pacira BioSciences，推进其创新药物战略，并成为非阿片类疼痛治疗领域的领导者

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies

CISION 等信源发布 2026-10-08 19:45



可切换为仅中文







Viatris logo

晖致标志

Pacira BioSciences logo

Pacira BioSciences 标志